Daewoong Pharmaceutical Co., Ltd's (KRX:069620) 27% Price Boost Is Out Of Tune With Earnings
Jul 24
South Korean (KOSPI) Pharma Industry Analysis
UpdatedJul 26, 2024
DataAggregated Company Financials
Companies98
- 7D-1.5%
- 3M9.5%
- 1Y14.8%
- YTD0.4%
Over the last 7 days, the Pharma industry has dropped 1.5%, driven by a pullback from Sam Chun Dang Pharm of 9.6%. Meanwhile, Daewoong Pharmaceutical actually outperformed within the industry, gaining 11% in the last week. This takes the industry's 12 month performance to a gain of 15%. Looking forward, earnings are forecast to grow by 37% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jul 2024 | ₩55.3t | ₩28.4t | ₩762.2b | 14.8x | 72.5x | 1.9x |
| Sun, 23 Jun 2024 | ₩52.7t | ₩30.2t | ₩909.6b | 13.5x | 57.9x | 1.7x |
| Tue, 21 May 2024 | ₩54.4t | ₩29.7t | ₩936.7b | 17.9x | 58x | 1.8x |
| Thu, 18 Apr 2024 | ₩49.2t | ₩29.4t | ₩922.9b | 16.4x | 53.3x | 1.7x |
| Sat, 16 Mar 2024 | ₩53.2t | ₩29.7t | ₩822.3b | 20.1x | 64.7x | 1.8x |
| Mon, 12 Feb 2024 | ₩50.8t | ₩29.6t | ₩593.1b | 21.3x | 85.6x | 1.7x |
| Wed, 10 Jan 2024 | ₩54.4t | ₩29.6t | ₩588.5b | 23.8x | 92.4x | 1.8x |
| Fri, 08 Dec 2023 | ₩50.4t | ₩29.6t | ₩590.4b | 22.2x | 85.4x | 1.7x |
| Sun, 05 Nov 2023 | ₩46.5t | ₩29.3t | ₩683.3b | 15.8x | 68.1x | 1.6x |
| Tue, 03 Oct 2023 | ₩50.9t | ₩29.3t | ₩683.3b | 17.1x | 74.5x | 1.7x |
| Thu, 31 Aug 2023 | ₩51.0t | ₩29.3t | ₩691.0b | 20.2x | 73.8x | 1.7x |
| Sat, 29 Jul 2023 | ₩48.9t | ₩28.8t | ₩884.1b | 21.7x | 55.3x | 1.7x |
| Mon, 26 Jun 2023 | ₩47.5t | ₩28.9t | ₩908.3b | 20.8x | 52.3x | 1.6x |
| Wed, 24 May 2023 | ₩48.8t | ₩28.7t | ₩843.4b | 22.3x | 57.9x | 1.7x |
| Fri, 21 Apr 2023 | ₩48.2t | ₩28.5t | ₩602.7b | 21.3x | 80.1x | 1.7x |
| Sun, 19 Mar 2023 | ₩44.8t | ₩27.8t | ₩636.9b | 19.6x | 70.3x | 1.6x |
| Tue, 14 Feb 2023 | ₩45.0t | ₩27.7t | ₩743.5b | 19.6x | 60.5x | 1.6x |
| Thu, 12 Jan 2023 | ₩45.6t | ₩28.0t | ₩770.2b | 19.8x | 59.2x | 1.6x |
| Sat, 10 Dec 2022 | ₩46.4t | ₩28.0t | ₩770.7b | 19.1x | 60.2x | 1.7x |
| Mon, 07 Nov 2022 | ₩42.3t | ₩27.2t | ₩694.8b | 20.6x | 60.8x | 1.6x |
| Wed, 05 Oct 2022 | ₩42.6t | ₩27.2t | ₩694.8b | 20.4x | 61.3x | 1.6x |
| Fri, 02 Sep 2022 | ₩48.4t | ₩27.5t | ₩724.8b | 20x | 66.8x | 1.8x |
| Sun, 31 Jul 2022 | ₩51.3t | ₩26.7t | ₩475.9b | 23.4x | 107.7x | 1.9x |
| Tue, 28 Jun 2022 | ₩47.4t | ₩26.7t | ₩475.9b | 20.6x | 99.5x | 1.8x |
| Thu, 26 May 2022 | ₩53.5t | ₩26.3t | ₩599.8b | 24.8x | 89.2x | 2x |
| Sat, 23 Apr 2022 | ₩56.4t | ₩26.1t | ₩674.3b | 26.7x | 83.6x | 2.2x |
| Mon, 21 Mar 2022 | ₩57.6t | ₩25.4t | ₩986.9b | 23.8x | 58.4x | 2.3x |
| Wed, 16 Feb 2022 | ₩50.4t | ₩25.0t | ₩934.5b | 22x | 53.9x | 2x |
| Fri, 14 Jan 2022 | ₩57.9t | ₩25.0t | ₩934.5b | 25.2x | 61.9x | 2.3x |
| Sun, 12 Dec 2021 | ₩61.4t | ₩25.0t | ₩933.1b | 26x | 65.8x | 2.5x |
| Tue, 09 Nov 2021 | ₩60.0t | ₩24.7t | ₩875.4b | 23.8x | 68.6x | 2.4x |
| Thu, 07 Oct 2021 | ₩59.6t | ₩24.7t | ₩876.1b | 22.4x | 68x | 2.4x |
| Sat, 04 Sep 2021 | ₩74.3t | ₩26.0t | ₩960.3b | 40x | 77.4x | 2.9x |
| Mon, 02 Aug 2021 | ₩70.3t | ₩25.3t | ₩928.3b | 41.3x | 75.8x | 2.8x |
Price to Earnings Ratio
75.8x
Current Industry PE
- Investors are relatively neutral on the South Korean Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 71.3x.
- The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 6.4% per year over the last three years.
- Meanwhile revenues for these companies have grown 3.9% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -3.99% | |
| Healthcare | 1.34% | |
| Pharma | -1.52% | |
| Pharma | -1.52% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A068760 Celltrion Pharm | ₩98.40k | 5.2% +₩203.0b | 16.7% | n/a | |
| A069620 Daewoong Pharmaceutical | ₩130.00k | 10.0% +₩135.8b | 30.9% | PE13.1x | |
| A053030 BINEX | ₩21.90k | 15.9% +₩92.8b | 123.7% | PS5x | |
| A237690 ST PharmLtd | ₩93.90k | 3.2% +₩76.9b | 25.0% | PE83.9x | |
| A004310 Hyundai Pharmaceutical | ₩5.05k | 42.1% +₩41.4b | 20.2% | n/a |
